|
DATIA Members Appointed to DOT's Electronic Transmission and Storage of Drug Testing Information Advisory Committee
The Secretary of Transportation recently established the Department of Transportation (DOT) Electronic Transmission and Storage of Drug Testing Information Advisory Committee. The purpose of the committee is to recommend to the Department the type and level of electronic security that should be used for the transmission and storage of drug testing information generated as part of the DOT drug and alcohol testing program regulated by 40 CFR part 40 (65 FR 79462). Of those appointed, one-third of the committee members are also DATIA members.
The Committee will examine and provide advice to the DOT related to the format and methodology used in transmitting this type of information as well as the levels and procedures to use in implementing electronic signature technology within the context of the drug and alcohol program. The Committee will also provide advice and recommendations to DOT related to the level and type of electronic security that the Department should require in the use of electronic transmission and storage of drug testing information.
DATIA members appointed to the DOT Electronic Transmission and Storage of Drug Testing Information Advisory Committee are as follows:
| Type of DATIA Membership |
Company Representative |
Position Title |
Company & Office Location |
| Sustaining Member |
Barry Sample (Chairperson) |
Director of Science and Technology |
Quest Diagnostics Incorporated, Atlanta, GA |
| Corporate Member |
Karam Bedros |
Information Systems Manager |
MedTox Laboratories, St. Paul, MN |
| Member |
Michael Feldman |
VP & General Manager |
Northwest Toxicology, Inc., Salt Lake City, UT |
| Sustaining Member |
Neil Fortner |
VP, Laboratory Operations |
PharmChem, Inc., Fort Worth, TX |
| Sustaining Member |
Eric A. Hess |
Director, United Labs Division |
U.S. Investigative Services, Annandale, PA |
| Sustaining Member & Board Member |
Eric Quilter |
President & CEO |
Compliance Information Systems (CIS), Salt Lake City, UT |
| Member |
Lisa D. Tarnai |
Laboratory Director |
Scientific Testing Laboratories, Richmond, VA |
The DOT Electronic Transmission and Storage of Drug Testing Information Federal Advisory Committee will meet in a public session on June 17-18, 2002, at the J.W. Marriott Hotel, 1331 Pennsylvania Avenue, NW., Washington, DC 20004. The purpose of the Committee is to recommend to DOT the type and level of electronic security that should be used for the transmission and storage of drug testing information, to assess the type of format and methodology that would be appropriate, and to recommend the level and type of electronic signature technology that would support the procedures used in the DOT drug and alcohol program. Read the complete announcement in the Federal Register or download it (PDF).
|
|
|
|
|
